Trend

Last Previous Currency Date Chng
902.35 906.24 USD 25/12/15 -0.43

Terms

Isin LU0069152568
Contract Type Fondo Comune Inv.
Currency USD
Class P
Risk Class 5
Assogestioni Category Azionari Salute
Declared Benchmark 100% MSCI US Investable Market Biotechnology 10/40
Start Date 96/10/15
Advisor Name Nathalie Gabrielle L�tscher Petrus; Ubs Ag - Zurigo
Fund Asset Under Management 445,6394  at 23/03/31

Performance

Cumulatives
1 month +3.64
Ytd +23.23
1 year +18.74
3 years +11.92
5 years +16.91
Yearly
11/30/2024 -3.41
11/30/2023 -2.09
11/30/2022 -2.64
11/30/2021 +2.25
11/30/2020 +14.08
Rating
Score
21.9715

Company

Ubs Asset Mgmt (Europe) S.A.
33A avenue J.F. Kennedy L-1855 - Lussemburgo
Tel. N.Av.

Costs

Entrance (ACP) Min: 5,0000 - Max: 5,0000
Management 1.63
Reimbursement 0%
Administrative 0,41%
Switch 3%
Tunnel 0

Subscription

One Solution
Initial 0,0000 USD
Integrative 0,0000 USD
Accumulation Plan
Duration N.Av.
Minimum Payment Unit N.Av.
Initial Payment 0,0000

Costs

Entrance (ACP) Min: 5,0000 - Max: 5,0000
Management 1.63
Reimbursement 0%
Administrative 0,41%
Switch 3%
Tunnel 0

Performance

Cumulatives
1 day +0.10
1 week -0.34
1 month +3.64
3 months +21.93
6 months +35.67
From the beginning of the year +23.23
1 year +18.74
2 years +29.30
3 years +11.92
4 years +19.14
5 years +16.91
Yearly
11/30/2024 -3.41
11/30/2023 -2.09
11/30/2022 -2.64
11/30/2021 +2.25
11/30/2020 +14.08


Rating
Rating Rating Rating
Score
21.9715

Efficiency Indicators

Sharpe 1 year 0.5718
Benchmark 1 year N.Av.
Sharpe 3 years 0.0012
Benchmark 3 years N.Av.
Sharpe 5 years 0.2252
Benchmark 5 years N.Av.
Sortino 1 year 0.9162
Benchmark 1 year N.Av.
Sortino 3 years 0.0004
Benchmark 3 years N.Av.
Sortino 5 years 0.3491
Benchmark 5 years N.Av.

Absolute

Standard Volatility
1 year +23.19
3 years +19.85
5 years +19.11
Negative Volatility
1 year +14.60
3 years +13.28
5 years +12.21

Benchmark

Standard Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Negative Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Updated Monthly - 25/11/28

Relative

Sharpe 0.0012
Sortino 0.0004
Bull Market +5.91
Bear Market -3.40
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Three years data
Risk Class 5

General

  1 year 17,740 3 years 15,600 5 years 13,845
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 17,740
2,235
  
+16.62
3 years 15,600
15,613
  
+7.32
5 years 13,845
7,518
  
+20.53
Performance
2,235 +16.62 15,613 +7.32 7,518 +20.53
Total Volatility
1 year 17,740
21,321
  
+23.19
3 years 15,600
18,341
  
+19.85
5 years 13,845
15,790
  
+19.11
Total Volatility
21,321 +23.19 18,341 +19.85 15,790 +19.11
Negative Volatility
1 year 17,740
21,239
  
+14.60
3 years 15,600
18,762
  
+13.28
5 years 13,845
15,797
  
+12.21
Negative Volatility
21,239 +14.60 18,762 +13.28 15,797 +12.21
Sharpe Index
1 year 17,740
11,314
  
+0.57
3 years 15,600
15,923
  
+0.00
5 years 13,845
9,940
  
+0.23
Sharpe Index
11,314 +0.57 15,923 +0.00 9,940 +0.23
Sortino Index
1 year 17,740
11,011
  
+0.92
3 years 15,600
15,915
  
+0.00
5 years 13,845
9,662
  
+0.35
Sortino Index
11,011 +0.92 15,915 +0.00 9,940 +0.35

By Category

  1 year 17,740 3 years 15,600 5 years 13,845
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 17,740
16
  
+16.62
3 years 15,600
48
  
+7.32
5 years 13,845
46
  
+20.53
Performance
16 +16.62 48 +7.32 46 +20.53
Total Volatility
1 year 17,740
102
  
+23.19
3 years 15,600
90
  
+19.85
5 years 13,845
67
  
+19.11
Total Volatility
102 +23.19 90 +19.85 67 +19.11
Negative Volatility
1 year 17,740
102
  
+14.60
3 years 15,600
93
  
+13.28
5 years 13,845
69
  
+12.21
Negative Volatility
102 +14.60 93 +13.28 69 +12.21
Sharpe Index
1 year 17,740
14
  
+0.57
3 years 15,600
42
  
+0.00
5 years 13,845
43
  
+0.23
Sharpe Index
14 +0.57 42 +0.00 43 +0.23
Sortino Index
1 year 17,740
18
  
+0.92
3 years 15,600
42
  
+0.00
5 years 13,845
43
  
+0.35
Sortino Index
18 +0.92 42 +0.00 43 +0.35

Foreign Funds - Ubs (Lux) Eq. Fd Biotech P Cap $: Performance, Terms, Fees, Risk, Rating


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.